Bahinting, Jessa Mae .

HRN: 17-66-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CEFUROXIME 1.5GM (VIAL)
06/20/2025
06/21/2025
IV
1.5g
Anst Ptor
Repeat Cs
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: